188 related articles for article (PubMed ID: 16259644)
21. Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.
Majid MA; Smith VA; Matthews FJ; Newby AC; Dick AD
Br J Ophthalmol; 2006 Oct; 90(10):1310-5. PubMed ID: 16837541
[TBL] [Abstract][Full Text] [Related]
22. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.
Jacobson SG; Cideciyan AV; Regunath G; Rodriguez FJ; Vandenburgh K; Sheffield VC; Stone EM
Nat Genet; 1995 Sep; 11(1):27-32. PubMed ID: 7550309
[TBL] [Abstract][Full Text] [Related]
23. Sorsby's fundus dystrophy.
Weisinger HS; Pesudovs K
Optometry; 2001 Jul; 72(7):435-40. PubMed ID: 11486938
[TBL] [Abstract][Full Text] [Related]
24. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
[TBL] [Abstract][Full Text] [Related]
25. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy.
Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ
J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594
[TBL] [Abstract][Full Text] [Related]
26. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
[TBL] [Abstract][Full Text] [Related]
27. Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy.
Wolk A; Hatipoglu D; Cutler A; Ali M; Bell L; Hua Qi J; Singh R; Batoki J; Karle L; Bonilha VL; Wessely O; Stoehr H; Hascall V; Anand-Apte B
Cells; 2020 Mar; 9(3):. PubMed ID: 32143276
[TBL] [Abstract][Full Text] [Related]
28. [Genetic aspects of age-related macular degeneration].
Janik-Papis K; Zaraś M; Skłodowska A; Ulińska M; Borucka AI; Błasiak J
Klin Oczna; 2009; 111(4-6):178-82. PubMed ID: 19673454
[TBL] [Abstract][Full Text] [Related]
29. Sorsby's fundus dystrophy in two Japanese families with unusual clinical features.
Isashiki Y; Tabata Y; Kamimura K; Ohba N
Jpn J Ophthalmol; 1999; 43(6):472-80. PubMed ID: 10672875
[TBL] [Abstract][Full Text] [Related]
30. Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance.
Felbor U; Suvanto EA; Forsius HR; Eriksson AW; Weber BH
Am J Hum Genet; 1997 Jan; 60(1):57-62. PubMed ID: 8981947
[TBL] [Abstract][Full Text] [Related]
31. The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond.
Naessens S; De Zaeytijd J; Syx D; Vandenbroucke RE; Smeets F; Van Cauwenbergh C; Leroy BP; Peelman F; Coppieters F
Hum Mutat; 2019 May; 40(5):539-551. PubMed ID: 30668888
[TBL] [Abstract][Full Text] [Related]
32. [Age-related macular degeneration and genetics].
Souied E; Kaplan J; Coscas G; Soubrane G
J Fr Ophtalmol; 2001 Oct; 24(8):875-85. PubMed ID: 11894541
[TBL] [Abstract][Full Text] [Related]
33. Expression of mutant and wild-type TIMP3 in primary gingival fibroblasts from Sorsby's fundus dystrophy patients.
Arris CE; Bevitt DJ; Mohamed J; Li Z; Langton KP; Barker MD; Clarke MP; McKie N
Biochim Biophys Acta; 2003 May; 1638(1):20-8. PubMed ID: 12757930
[TBL] [Abstract][Full Text] [Related]
34. Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism.
Qi JH; Bell B; Singh R; Batoki J; Wolk A; Cutler A; Prayson N; Ali M; Stoehr H; Anand-Apte B
Sci Rep; 2019 Nov; 9(1):17429. PubMed ID: 31757977
[TBL] [Abstract][Full Text] [Related]
35. Sorsby's pseudoinflammatory macula dystrophy--Sorsby's fundus dystrophies.
Capon MR; Polkinghorne PJ; Fitzke FW; Bird AC
Eye (Lond); 1988; 2 ( Pt 1)():114-22. PubMed ID: 2457521
[TBL] [Abstract][Full Text] [Related]
36. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice.
Fu L; Garland D; Yang Z; Shukla D; Rajendran A; Pearson E; Stone EM; Zhang K; Pierce EA
Hum Mol Genet; 2007 Oct; 16(20):2411-22. PubMed ID: 17666404
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation at the N-terminal domain of the TIMP3 gene in Sorsby fundus dystrophy.
Schoenberger SD; Agarwal A
Retina; 2013 Feb; 33(2):429-35. PubMed ID: 23023527
[TBL] [Abstract][Full Text] [Related]
38. Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation.
Sieving PA; Boskovich S; Bingham E; Pawar H
Trans Am Ophthalmol Soc; 1996; 94():275-94; discussion 295-7. PubMed ID: 8981701
[TBL] [Abstract][Full Text] [Related]
39. Generation of an induced pluripotent stem cell line (SJTUGHi003-A) from a patient with Sorsby fundus dystrophy carrying c.484G>A mutation in TIMP3 gene.
Zhu X; Tang L; Zhang T; Bai X; Chen J; Zhang L; Gong Y; Jiang M; Sun X
Stem Cell Res; 2024 Jun; 77():103423. PubMed ID: 38640637
[TBL] [Abstract][Full Text] [Related]
40. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
